Increased markers of thrombogenesis in chronic atrial fibrillation: Effects of warfarin treatment

Heart

Volumn 73, Issue 6, 1995, Pages 527-533

  Lip, Gregory Y H ^a   Lowe, Gordon D O ^b   Rumley, Ann ^b   Dunn, Francis G ^c  

^a STOBHILL HOSPITAL   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FIBRIN; FIBRINOGEN; VON WILLEBRAND FACTOR; WARFARIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK FACTOR; THROMBOEMBOLISM; THROMBOGENESIS;

ADULT; AGED; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; THROMBOSIS; VON WILLEBRAND FACTOR; WARFARIN;

EID: 0029011363     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.73.6.527     Document Type: Article

References (0)